experimental group:CART cells
Sponsors
Qilu Hospital of Shandong University, Anhui Provincial Cancer Hospital, Tumor Hospital affiliated to Fudan University, The Affiliated Hospital of Qingdao University, Shanghai Tenth People's Hospital
Conditions
Advanced colorectal cancerAdvanced pancreatic cancerAdvanced solid tumorDigestive tract tumors, including colorectal cancer, gastric cancer, pancreatic cancer, esophageal adenocarcinoma, esophagogastric junction cancer, etcLate colorectal cancercolorectal cancer
Early Phase 1
Chimeric Antigen Receptor T Cells (CART) Therapy in colorectal cancer
Active, not recruitingChiCTR1900024041
Start: 2019-06-24Updated: 2020-04-20
Chimeric Antigen Receptor T Cells (CART) Therapy in Digestive system tumors
RecruitingChiCTR2100042879
Start: 2021-02-22Updated: 2021-05-17
Phase I Clinical Study on the Safety and Efficacy of CART Cells in the Treatment of Advanced Pancreatic Cancer
RecruitingChiCTR2100054734
Start: 2022-01-14Updated: 2022-12-05
Clinical study on the safety and efficacy of CART cells in the treatment of advanced MSLN positive tumors
RecruitingChiCTR2100054914
Start: 2021-12-31Updated: 2022-12-12
Clinical study on the safety and effectiveness of CAR-T cells in the treatment of advanced colorectal cancer
RecruitingChiCTR2200055852
Start: 2022-01-24Updated: 2023-07-02
Clinical study on the safety and effectiveness of CART cells in the treatment of advanced refractory GUCY2C-positive advanced colorectal cancer
RecruitingChiCTR2200055891
Start: 2022-01-24Updated: 2023-07-02